14. Business Segments and Customers

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service and support activities.

For fiscal years 2013, 2012 and 2011, no customer individually accounted for more than 10% of our revenues.

Revenue information shown by geographic region is as follows (in thousands):

	FY 2013 Year Ended December 28, 2013		FY 2012 Year Ended December 29, 2012		FY 2011 Year Ended December 31, 2011
United States	$	21,043	$	18,496	$	18,447
Europe		7,345		7,468		8,940
Rest of Americas		3,309		2,335		2,287
Asia/Pacific Rim		6,576		5,560		3,485
	$	38,273	$	33,859	$	33,159

Revenues are attributed to countries based on location of end customers. For fiscal years 2013, 2012 and 2011 no individual country accounted for more than 10% of the Company’s sales, except for the United States, which accounted for 55.0%, 54.6%, and 55.6% of revenues in 2013, 2012, and 2011 respectively.

As of December 28, 2013 and December 29, 2012, the Company had no long-lived assets in any country other than in the United States.